Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden.
PURPOSE: Clinical guidelines for cardiometabolic risk management indicate a simple threshold-based strategy for treatment, but physicians and their patients may be reluctant to modify drug treatment after a single elevated measurement. We determined how repeated measurements of blood pressure, chole...
| Publicado en: | Quality & Safety in Health Care Vol. 19; no. 5; pp. 411 - 416 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
BMJ Publishing Group
Oct2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |